ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.068,21
0,26%
S&P 500
5.473,23
0,77%
Dow Jones
38.778,10
0,49%
Euro vs US Dollar
1,07396
-0,01%
Bitcoin
66.245,03
-0,36%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Innate Pharma (PK) (IPHYF)

  7. Innate Pharma (PK) (IPHYF) News

IPHYF

Innate Pharma (PK) (IPHYF)

Innate Pharma (PK)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:IPHYF
DatumZeitQuelleÜberschriftSymbolFirma
17/06/202412h02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
14/05/202412h07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
07/05/202412h03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
06/03/202412h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
06/03/202412h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
21/02/202412h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
06/02/202423h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
06/02/202423h00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]USOTC:IPHYFInnate Pharma (PK)
19/12/202312h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
18/12/202317h40Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
11/12/202312h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
11/12/202312h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
27/11/202312h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
07/11/202312h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
16/10/202312h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
05/10/202312h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
22/09/202312h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
10/08/202312h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
26/06/202312h03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPHYFInnate Pharma (PK)
12/06/202312h45Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPHYFInnate Pharma (PK)
12/06/202312h44Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPHYFInnate Pharma (PK)
08/06/202312h02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPHYFInnate Pharma (PK)
07/06/202312h03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPHYFInnate Pharma (PK)
26/05/202312h05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPHYFInnate Pharma (PK)
15/05/202312h28Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPHYFInnate Pharma (PK)
12/05/202322h01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPHYFInnate Pharma (PK)
10/05/202312h05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPHYFInnate Pharma (PK)
09/05/202312h05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPHYFInnate Pharma (PK)
26/04/202322h04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPHYFInnate Pharma (PK)
26/04/202322h03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPHYFInnate Pharma (PK)
 Showing the most relevant articles for your search:USOTC:IPHYF

Kürzlich von Ihnen besucht

NYSE
MCD
McDonalds
CCOM
US30
US 30
COIN
ETHUSD
Ethereum
PM
XAUUSD
Gold vs US Dollar
TG
MBG
MercedesBenz
AMEX
XLF
Financial Select Sector
USOTC
RHHBY
Roche (QX)
USOTC
ADDYY
Adidas (QX)
NASDAQ
GOOGL
Alphabet
DBI
SDXP
SDAX
NASDAQ
AMZN
Amazon.com
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
AAPL
Apple
USOTC
BNPQY
BNP Paribas (QX)
TG
BAS
BASF
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten